CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Need to increase efficiency in healthcare institutions
4.1.2. Increasing concerns for patient safety
4.1.3. Need for better asset management in hospitals
4.1.4. The decline in prices of RFID (Radio-frequency identification) tags
4.2. Market Restraints & Challenges
4.2.1. Data privacy concerns
4.2.2. Accuracy issues with the devices
4.2.3. The high cost of RFID readers
4.3. Market Opportunities
4.3.1. IOT-based healthcare asset management (IOT-HAM)
4.3.2. Expanding application areas of healthcare asset management solutions
4.3.3. Technological advancements
4.3.4. Emerging Economies
CHAPTER 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET – BY
PRODUCT
5.1. Radiofrequency Identification (RFID) Devices
5.1.1 Hardware
5.1.2 Software
5.1.3 Services
5.2. Real-Time Location Systems (RTLS)
5.3.1 Hardware
5.3.1.1 Tags/Badges
5.3.1.2 Readers/Interrogators
5.3.2 Software
5.3.3 Services
5.4. Ultrasound & Infrared Tags
CHAPTER 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET – BY
APPLICATION
6.1. Hospital Asset Management
6.1.1 Equipment Tracking and Management
6.1.2 Patient Management
6.1.3 Temperature and Humidity Monitoring
6.1.4 Staff Management
6.1.5 Infection Control and Hand Hygiene Compliance
6.2. Pharmaceutical Asset Management
6.2.1 Drug Anti-Counterfeiting
6.2.2 Supply Chain Management
CHAPTER 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET – BY
END USER
7.1. Hospital/Clinic
7.2. Laboratory
7.3. Pharmaceutical
7.4. Bio-Technology
CHAPTER 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET -
COMPANY PROFILES
9.1. Airista Flow
9.2. Elpas
9.3. GE Healthcare (A General Electric Company)
9.4. Centrak
9.5. IBM Corporation
9.6. Intelligent Insites
9.7. Thingmagic (A Novanta Company)
9.8. Sonitor
9.9. Stanley Black & Decker, Inc.
9.10. Versus Technology (A Midmark Company)
9.11. Zebra Technologies
9.12. Radianse Technologies
9.13. Awarepoint Corporation
9.14. INFOR Inc.
9.15. Motorola Solutions
CHAPTER 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
